Cerevel Therapeutics Hldg: Q1 Earnings Insights

Cerevel Therapeutics Hldg CERE reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Cerevel Therapeutics Hldg reported in-line EPS of $-0.67 versus an estimate of $-0.67.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 0.71% drop in the share price the next day.

To track all earnings releases for Cerevel Therapeutics Hldg visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.